Hydroxyapatite Market

Hydroxyapatite Market Size (2023-2028)

The Hydroxyapatite Market is valued at USD 2.34 billion in 2022 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.4 % during the forecast period to become a USD 3.04 billion market in 2028.

Hydroxyapatite, the mineral form of calcium apatite, consists of a phosphate and a hydroxyl group. It is an important component of teeth that provides high stiffness and better enamel remineralization than saliva. Hydroxyapatite coatings in orthopedic implants and dental care products offer improved properties, including increased bone-to-hydroxyapatite healing, faster bone healing at the bone-implant interface, and corrosion inhibition. Manufacturers are replacing conventional titanium plasma coatings with nanohydroxyapatite coatings. It is a calcium phosphate similar to hard human tissue in its morphology and composition. Hydroxyapatite has been widely used in clinical bone applications. A significant property of hydroxyapatite is its stability in comparison to other calcium phosphates. The escalating interest in hydroxyapatite is owing to its chemical composition which is the same as that of the inorganic component of natural bone. Hydroxyapatite is commercially available either from a natural source or as a synthetic hydroxyapatite. The important treatment parameters of hydroxyapatite are sintering temperature, stoichiometry, phase purity, particle size of the particles, and porosity.

Hydroxyapatite Market Drivers and Restraints:

The global hydroxyapatite market is expected to grow at a rapid rate throughout the foreseen period owing to escalated customer awareness of bioactive ceramics and escalating healthcare expenses worldwide. Hydroxyapatite (HA) is an important component of normal bones and teeth that is already used as a coating in orthopedic implants to promote bone fixation and expansion. The escalating call for dental and orthopedic implants, together with the escalating popularity of bioactive materials and solid investments in R&D activities to expand hydroxyapatite applications, should stimulate the expansion of the global HAp market over the outlook period.

Hydroxyapatite is an osteoconductive and biocompatible material that is added to the fundamental segment of bone. Silver-coated or silver-containing HAp integration strategies incorporate the sol-gel technique, the wet synthesis strategy, particle trading, and hot spatter. To maintain the antibacterial movement of the material in vivo, silver must remain in an ionic state and be firmly adhered to the coated surface. A new safe hydroxyapatite film for a microscopic organism in which ionic silver is constructed to immobilize these organisms using inositol hexaphosphate chelation via a low heat flood process. The safe coating of this microorganism has shown tremendous antibacterial movement in vitro and in vivo. Hydroxyapatite is used as a characteristic bone substitute in orthopedic applications. It is also generally used to coat metal inserts in order to enhance their biocompatibility. The maturation of the population and the development of the availability and reasonableness of orthopedic drugs stimulate the development of orthopedic applications that are part of the hydroxyapatite market.

The escalating consumption of hydroxyapatite, due to the increase in research and development activities aimed at escalating the applicability of hydroxyapatite in the medical sector, is a crucial factor in the expansion of the global hydroxyapatite market. Also, the increase in the consumption of hydroxyapatite worldwide, due to the escalating call for dental implants, is another factor that should stimulate expansion in the target market during the forecast period. Moreover, the surge in developments in the healthcare sector and easy access to raw materials are other factors that are foreseen to promote the expansion of the global hydroxyapatite market in the future.

However, the low mechanical resistance of hydroxyapatite is an essential factor that is supposed to limit the expansion of the global hydroxyapatite market during the conjecture period.

HYDROXYAPATITE MARKET REPORT COVERAGE:

Market Segmentation:

Hydroxyapatite Market - By Type:

• Nano-size
• Micro-size
• Greater than Micrometers

The nano-size sector is known to hold a substantial share of the global Hydroxyapatite industry in the year 2020.

Hydroxyapatite Market - By Application:

• Orthopedic
• Dental Care
• Plastic Surgery
• Others

The orthopedic sector is dominating the Hydroxyapatite industry in 2021 and is predicted to dominate the industry throughout the foreseen period also.

Hydroxyapatite Market - By Region:

The Hydroxyapatite report includes the segmentation of Regions with their respective Countries.

• North America Hydroxyapatite Industry includes the U.S. and Canada.

• Europe Hydroxyapatite Industry includes the UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

• Asia Pacific Hydroxyapatite Industry includes India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

• Latin America Hydroxyapatite Industry includes Brazil, Mexico, Argentina, Chile & Rest of LATAM.

• Middle East & Africa Hydroxyapatite Industry includes KSA, UAE, Israel, the rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA.

The North American region accounted for the majority of the global hydroxyapatite market in 2019. It is also expected to experience significant expansion in the market during the conjecture period. The hydroxyapatite market in the Asia-Pacific is expected to grow at the highest CAGR over the outlook period. The increased call for hydroxyapatite in Asian countries is stimulating the expansion of the hydroxyapatite market in this area. Moreover, an aging population, escalating disposable incomes, and escalating combined awareness of the advantages of dental bone grafting over conventional treatments provide a huge opportunity for expansion for hydroxyapatite makers in the region of Asia-Pacific.

Currently, the North American market represents the largest market share in the world hydroxyapatite market in terms of income. This can be attributed to the presence of the main hydroxyapatite manufacturers in the region. The Asia Pacific market is also expected to experience significant expansion during the forecast period due to increased call for hydroxyapatite due to increased aging and population awareness.

Recent Developments in the Hydroxyapatite Market Industry: 

• Prominence and Onkos Surgical partnered on hydroxyapatite surface technology in limb salvage surgery. Onkos Surgical Inclusive has declared that it has come into partnership with Promimic AB to commercialize Promimic's proprietary Hydroxyapatite (HA) Surface Technologies in Limb Salvage Surgery.

• Medtronic has declared the introduction of its KYPHON ActivOs 10 Bone Cement with Hydroxyapatite. Polymethylmethacrylate bone cement is for employment in the treatment of patients with vertebral compression fractures suffering very less invasive surgery with KYPHON Balloon Kyphoplasty.

Hydroxyapatite Market Key Players:

1. FLUIDINOVA (Portugal)
2. SofSera Corporation (Japan)
3. Berkeley Advanced Biomaterials (US)
4. Taihei Chemical Industrial Co. Ltd. (Japan)
5. SigmaGraft (US)
6. CAM Bioceramics (Netherlands)